Login / Signup

Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab.

Pablo López SanzMarta Guzmán PérezJosé Manuel Azaña DefezClaudia Guerrero RamírezSilvia Manso CórdobaMaría Encarnación Alfaro Martínez
Published in: Clinical and experimental dermatology (2023)
Keyphrases
  • hidradenitis suppurativa
  • protein kinase
  • tyrosine kinase
  • replacement therapy